Review



mouse anti-human braf v600e monoclonal antibody (clone ve1)  (Spring Bioscience)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Spring Bioscience mouse anti-human braf v600e monoclonal antibody (clone ve1)
    Lymphocyte biomarkers and distribution by BRAF mutation status
    Mouse Anti Human Braf V600e Monoclonal Antibody (Clone Ve1), supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-human+braf+v600e+monoclonal+antibody+(clone+ve1)/braf+v600e+antibody/pmc07801318-75-1-6
    Average 90 stars, based on 1 article reviews
    mouse anti-human braf v600e monoclonal antibody (clone ve1) - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy"

    Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

    Journal: Annals of Surgical Oncology

    doi: 10.1245/s10434-020-08713-1

    Lymphocyte biomarkers and distribution by BRAF mutation status
    Figure Legend Snippet: Lymphocyte biomarkers and distribution by BRAF mutation status

    Techniques Used: Mutagenesis

    Clinical response to DPCP correlated with OS by biomarker status
    Figure Legend Snippet: Clinical response to DPCP correlated with OS by biomarker status

    Techniques Used: Biomarker Discovery

    Related Articles

    Immunohistochemistry:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

    Avidin-Biotin Assay:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

    Blocking Assay:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

    Incubation:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

    Sequencing:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

    Staining:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

    Activity Assay:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

    Binding Assay:

    Article Title: Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Article Snippet: Purpose: To evaluate the application of whole genome sequencing (WGS) in determining the inter-foci clonal relationship of multifocal papillary thyroid carcinoma (mPTC).. Methods: After reviewing PTC patient profiles, 8 cancer foci and germline control samples from 3 mPTC patients were analyzed by WGS.. Single nucleotide variations (SNVs), copy number variation (CNV), structural variation and mutational signature were examined.

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Article Title: A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
    Article Snippet: Background In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread.. However, it appears that amelanotic melanomas frequently lack BRAF mutations.. Objective To report the genetical analysis of one case amelanotic melanoma developing oral metastasis.

    Article Title: Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
    Article Snippet: Hui Liu,* Zhongwu Li,* Yan Wang, Qin Feng, Lu Si, Chuanliang Cui, Jun Guo and Weicheng Xue Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute and Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China



    Similar Products

    90
    Spring Bioscience mouse anti-human braf v600e monoclonal antibody (clone ve1)
    Lymphocyte biomarkers and distribution by BRAF mutation status
    Mouse Anti Human Braf V600e Monoclonal Antibody (Clone Ve1), supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-human+braf+v600e+monoclonal+antibody+(clone+ve1)/braf+v600e+antibody/pmc07801318-75-1-6
    Average 90 stars, based on 1 article reviews
    mouse anti-human braf v600e monoclonal antibody (clone ve1) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Spring Bioscience mouse monoclonal anti-human braf v600e antibody clone ve1
    Lymphocyte biomarkers and distribution by BRAF mutation status
    Mouse Monoclonal Anti Human Braf V600e Antibody Clone Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-human+braf+v600e+monoclonal+antibody+(clone+ve1)/braf+v600e+antibody/pm29241739-52-7-17
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-human braf v600e antibody clone ve1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Spring Bioscience mouse anti-human braf v600e monoclonal antibody clone ve1
    Clinical-pathological characteristics of patients and BRAF <t> V600E </t> immunostain intensity.
    Mouse Anti Human Braf V600e Monoclonal Antibody Clone Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-human+braf+v600e+monoclonal+antibody+(clone+ve1)/braf+v600e+antibody/pmc06246660-42-29-37
    Average 90 stars, based on 1 article reviews
    mouse anti-human braf v600e monoclonal antibody clone ve1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Spring Bioscience mouse anti-human braf v600e specific monoclonal antibody clone ve1
    Clinical-pathological characteristics of patients and BRAF <t> V600E </t> immunostain intensity.
    Mouse Anti Human Braf V600e Specific Monoclonal Antibody Clone Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-human+braf+v600e+monoclonal+antibody+(clone+ve1)/braf+v600e+antibody/pmc04129051-52-11-15
    Average 90 stars, based on 1 article reviews
    mouse anti-human braf v600e specific monoclonal antibody clone ve1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Lymphocyte biomarkers and distribution by BRAF mutation status

    Journal: Annals of Surgical Oncology

    Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

    doi: 10.1245/s10434-020-08713-1

    Figure Lengend Snippet: Lymphocyte biomarkers and distribution by BRAF mutation status

    Article Snippet: For BRAF V600E IHC, Pleasanton, CA Spring Bioscience mouse anti-human BRAF V600E monoclonal antibody (Clone VE1) was used at a dilution of 1:200 run on a routine long program.

    Techniques: Mutagenesis

    Clinical response to DPCP correlated with OS by biomarker status

    Journal: Annals of Surgical Oncology

    Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

    doi: 10.1245/s10434-020-08713-1

    Figure Lengend Snippet: Clinical response to DPCP correlated with OS by biomarker status

    Article Snippet: For BRAF V600E IHC, Pleasanton, CA Spring Bioscience mouse anti-human BRAF V600E monoclonal antibody (Clone VE1) was used at a dilution of 1:200 run on a routine long program.

    Techniques: Biomarker Discovery

    Clinical-pathological characteristics of patients and BRAF  V600E  immunostain intensity.

    Journal: Frontiers in Oncology

    Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas

    doi: 10.3389/fonc.2018.00526

    Figure Lengend Snippet: Clinical-pathological characteristics of patients and BRAF V600E immunostain intensity.

    Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

    Techniques: Sequencing